News|Articles|April 2, 2004
- Pharmaceutical Technology-04-02-2004
- Volume 28
- Issue 4
Synthetic Excipients Challenge All-Natural Organics
Author(s)Ronelle Russell
Synthetic excipients frequently offer advantages over all-natural compounds.
Advertisement
Articles in this issue
over 22 years ago
Spotlight on Business Riskover 22 years ago
Vibration Technology for Active Dry-Powder Inhalersover 22 years ago
In the Spotlight April 2004over 22 years ago
FDA Attacks Counterfeitsover 22 years ago
April 2004over 22 years ago
Controlled-Release Dosage Forms for Diltiazem HydrochlorideAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
3
Overcoming Raw-Material Variability Challenges for Autologous Adoptive Cell Therapies
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5